Stay updated on ADMEC-O: Clinical Trial of Immunotherapy vs Observation
Sign up to get notified when there's something new on the ADMEC-O: Clinical Trial of Immunotherapy vs Observation page.

Latest updates to the ADMEC-O: Clinical Trial of Immunotherapy vs Observation page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added, and the previous notices for government funding and operating status (Revision: v3.4.1) were removed. These are administrative updates and do not impact the trial data or study details.SummaryDifference0.4%

- Check20 days agoChange DetectedAdded a site-wide funding/status notice and a version update (Revision: v3.4.1); removed the previous revision note (Revision: v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedThese changes are minor UI/label updates, including a new Show glossary control, capitalization tweaks (Last Update Submitted that Met QC Criteria, No FEAR Act Data), and a version label (Revision: v3.4.0). They do not modify core study details, endpoints, or eligibility criteria, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedMinor page update: Revision: v3.3.4 added and Revision: v3.3.3 removed; no substantive changes to study content or layout are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a new 'Locations' section listing North Rhine-Westphalia and updated the page revision to v3.3.3; the HHS Vulnerability Disclosure link was removed.SummaryDifference0.2%

- Check85 days agoChange DetectedA new revision label (v3.3.2) is shown, replacing the previous v3.3.1. No other content or data on the page appears to be altered.SummaryDifference0.0%

Stay in the know with updates to ADMEC-O: Clinical Trial of Immunotherapy vs Observation
Enter your email address, and we'll notify you when there's something new on the ADMEC-O: Clinical Trial of Immunotherapy vs Observation page.